Myriad Genetics, Inc. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$825M
Cost of Revenue
$248M
Gross Profit
$577M
R&D
$107M
SG&A
—
D&A
$54M
Operating Income
$-387M
EBITDA
$-334M
Interest Expense
$11M
Interest Income
$2M
Other Income/Expense
$800K
Pretax Income
$-395M
Tax Provision
$-29M
Net Income
$-366M
Gross Margin
69.9%
Operating Margin
-47.0%
Net Margin
-44.4%
Effective Tax Rate
7.4%
Deferred Tax Assets
$32M
Deferred Tax Liabilities
$3M
DTA Valuation Allowance
$151M
Tax Credit Carryforwards
—
NOL Carryforwards
$83M
ETR (Continuing Operations)
7.4%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-0.1%
ETR Foreign Differential (pp)
0.0%
Revenue YoY Variation
-1.6%
Income YoY Variation
-213.5%